Spinifex Announces Start of Phase 2 Proof-of-Concept Trial of EMA401 in CIPN

News   Dec 10, 2012

 
Spinifex Announces Start of Phase 2 Proof-of-Concept Trial of EMA401 in CIPN
 
 
 

RELATED ARTICLES

Robust Multiplex Mass Spectrometric Assay for Screening Small-Molecule Inhibitors

News

A new original research article presents a fast, sensitive, and robust methodology for screening small molecule inhibitors against CD73/Ecto-5'-Nucleotidase, a promising target for developing anti-cancer drugs.

READ MORE

Protein's Role in Mitochondrial Metabolism Identified

News

EXD2, a protein previously thought to be localised to the nucleus, has a key role in the production of proteins by mitochondria.

READ MORE

PPD and Quotient Sciences Form Innovative Partnership to Accelerate Pediatric Drug Development

News

Will shorten timelines, reduce costs and simplify contracting process in pediatric programs.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Cancer Research Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE